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Background: Cardiovascular disease is the primary cause of death in the US. Hundreds of clinical trials have been performed to guide practice 
to decrease morbidity and mortality in patients with cardiovascular disease. There is scant data comparing various disease states for cardiac and 
noncardiac mortality.
Methods: To determine the relative risk of cardiac, noncardiac, and total mortality in different cardiovascular diseases, we evaluated the control 
arm in 121 clinical trials with at least 900 patients per arm and a minimum of 1 year of follow-up, published in JAMA, NEJM or Lancet since 1998. 
We calculated the expected number of deaths for a similarly age and gender matched population and compared these to reported cardiac and total 
mortality. Results are presented as a percentage of expected.
Results: Ten studies had higher than expected noncardiac mortality, primarily in CHF (5/19). The number of deaths was 50% of expected in the 
primary prevention studies. Hypertension doubled cardiac mortality risk, while having diabetes, stable CAD or stroke doubled the risk again to twice 
expected. Patients with recent MI’s had twice the mortality of patients with stable CAD. Patients with heart failure had an additional 3 fold increase 
in cardiac mortality. End stage renal patients had the highest mortality.
Conclusions: There is a gradation of mortality risk with different cardiovascular processes, though stable CAD, diabetes, and stroke all appear to 
have similar cardiovascular mortality risk.
Disease State # of Studies Mean Age % Male Total Mortality Cardiac Mortality
Noncardiac 
Mortality
Primary Prevention 15 62.2 35 44% 45% 49%
Hypertension (+1 RF) 15 64.9 55 65% 116% 49%
Diabetes 7 60.6 58 85% 162% 64%
Stable CAD 32 63.9 61 96% 187% 61%
CVA 7 64.7 64 113% 205% 77%
Atrial Fibrillation 4 70.7 60 108% 260% 52%
Acute MI (< 30 Days 20 62.9 70 208% 406% 68%
CHF 19 65.4 68 404% 1210% 128%
ESRD 2 65.3 81 530% 1740% 710%
